Skip to main content
. Author manuscript; available in PMC: 2018 Aug 30.
Published in final edited form as: Am J Transplant. 2016 Jul 12;16(12):3540–3547. doi: 10.1111/ajt.13917

Table 2.

Cumulative Incidence of end stage renal disease (ESRD) following live kidney donation, United States, October 1, 1987 – July 31, 2014

Year Cumulative Incidence of ESRD per 10,000 donors
By Cause of ESRDa

Diabetes (n=33)b Hypertension (n=70)c Glomerulonephritis (n=55)d
5 0.000.100.70 0.100.300.90 0.300.701.50
10 0.100.401.20 1.202.003.20 2.293.404.90
15 1.102.003.59 5.407.4010.1 4.596.308.60
20 5.808.9013.6 11.515.320.7 8.1011.115.3
25 9.6914.822.7 20.228.239.2 9.1912.817.8
a

Cause of ESRD as per the CMS form 2728 narrative (18)

b

Type II, adult-onset type or unspecified type diabetes; and Type I, juvenile type, ketosis prone diabetes

c

Renal disease due to hypertension (no primary renal disease); renal artery stenosis; renal artery occlusion; and, cholesterol emboli, renal emboli

d

Glomerulonephritis (GN) includes GN (histology not examined); focal segmental GN; membranous nephropathy; membranoproliferative GN; dense deposit disease; IgA nephropathy; IgM nephropathy (proven by immunofluorescence); rapidly progressive GN; Goodpasture’s syndrome; post infectious GN; and other proliferative GN.